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Introduction
Autosomal dominant polycystic kidney disease (ADPKD) is the most common monogenic disease and affects 1 in 1000 individuals in the general population. ADPKD leads to end stage renal disease in a large proportion of patients, however it is not limited to the kidney. Extrarenal manifestations include, among others, cysts in other organs, for example liver and pancreas, intracranial aneurysms (ICANs), and arterial hypertension (AH). ADPKD is a consequence of a mutation in polycystin-1 or 2 gene [1] . Vascular manifestations of the disease are due to the fact that both polycystins are expressed within arterial smooth muscle cells [2] [3] [4] , and a systemic vascular defect was observed already on oligosymptomatic stage of the disease [5, 6] . In effect, ADPKD patients are at risk for arterial complications [7] .
The frequency of ICANs is increased in ADPKD compared to the general population [8] and is estimated to 4-22.5% [9, 10] . The subarchnoid hemorrhage (SAH) due to the rupture of ICAN in ADPKD occurs more often and at younger age compared to the general population [11, 12] , and is connected to high risk of death or serious complications [13, 14] . The overall prevalence of AH in ADPKD may exceed 80% [15] . AH is a well-known risk factor for both the progression of chronic kidney disease (CKD) [16] , and cardiovascular complications [17, 18] , which are the main cause of death in ADPKD population in the dialysis era [19] .
Although AH is a risk factor for SAH in the general population [20] , it is not considered as a risk factor for ICANs formation in ADPKD [11, 21] . We attempted to verify that thesis in a group of ADPKD patients in which both screening for ICANs with magnetic resonance (MR) angiography of the brain, and assessment of blood pressure (BP) with ambulatory blood pressure monitoring (ABPM) were carried out.
Materials and Methods
In 68 patients, 25 (36.8%) male and 43 (63.2%) female, with ADPKD diagnosed according to the unified ultrasonographic criteria [22] both MR angiography of the brain, and ABPM have been performed between June 2009 and October 2012. The design and results of the MR study have already been reported [23] . ABPM examinations were carried out at the Medical University of Warsaw's Department of Immunology, Transplant Medicine and Internal Diseases using Space Labs devices, models 90207, or 90217; and analyzed with ABP Report Management System (Space Labs Medical, Inc.), version 1.03.16, software. Data on minimal, mean, and maximal diastolic blood pressure (DBPmin, DBPmean, and DBPmax, respectively), minimal, mean, and maximal systolic blood pressure (SBPmin, SBPmean, and SBPmax, respectively), minimal, mean, and maximal mean arterial pressure (MAPmin, MAPmean, and MAPmax, respectively), minimal, mean, and maximal heart rate (HRmin, HRmean, and HRmax, respectively), were recorded for each case. Additionally, standard deviations (SD) for DPB (DBP SD ), SBP (SBP SD ), MAP (MAP SD ), and HR (HR SD ) in the 24 hours, during the daytime, and during the nighttime were analysed. We also calculated 24-hour pulse pressure (24-hPP), and maximum daytime and nighttime increases in SBP and DBP from measurement to measurement (positive deltas of SBP and DBP).
All included patients were Caucasians and all were in pre-dialysis period of the disease. 
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Table 1. Characteristics of groups
Statistical analysis
Statistical analysis was performed using Statistica, ver. 10, software. The Mann-Whitney U and Fisher's exact tests were used when appropriate. P<0.05 was considered statistically significant. Results were presented as mean±standard deviation (SD), unless otherwise stated.
Results
Ten patients were diagnosed with ICANs (ICAN (+) group), while in 58 were not (ICAN (-) group). The comparison of these both groups is shown on Tab. 1 in ICAN (-) ; P=0.030). However, these groups were not fully comparable; in the ICAN (+) group, the mean age was significantly higher, and the kidney function assessed by GFR significantly worse compared to the ICAN (-) group (Tab. 1). While ICANs were detected only in patients above 45 years-of-age, we decided to perform further analysis in subgroups of patients older than 45 years (ICAN (+) group; and ICAN (-) 45+ subgroup), in which the demographic and renal function parameters were comparable, as shown on Tab. 2. During ABPM, the ICAN (+) patients had significantly higher 24- including maximum SBP/DBP values shown automatically by software and increases in DBP from measurement to measurement calculated manually may be helpful in selection of ADPKD patients who should undergo screening for ICANs. However, it should be emphasized that normotensive patients with ADPKD are also at risk for ICAN development [25] .
In summary, we feel that hypertensive ADPKD patients with substantial fluctuations in BP assessed by ABPM as high maximum SBP/DBP values and/or high increases in DBP from measurement to measurement, especially those after 45 years-of-age, should become candidates for screening for ICANs. On the other hand, we identified only one of possible risk factors for ICANs, because, as reported previously, increased BP is not a necessary factor for the development of ICAN and its rupture [13, 25] . A prospective study including larger number of cases is needed to confirm our findings and establish threshold values of BP suggesting high risk of development of an ICAN.
Conclusions
Due to the common, ciliopathy-related pathomechanism, development of ICANs in hypertensive ADPKD patients is accompanied with the higher values of some blood pressure parameters measured by ABPM. Hypertensive ADPKD patients with substantial fluctuations in BP assessed by ABPM as high maximum SBP/DBP values and/or high increases in DBP from measurement to measurement, especially those after 45 years-of-age, should become candidates for screening for ICANs.
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